301 related articles for article (PubMed ID: 29600576)
41. Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin.
Eljaaly K; Alshehri S; Erstad BL
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437617
[TBL] [Abstract][Full Text] [Related]
42. Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants.
Hagmann SHF; Hodle T; Brennan M; Szczerba F; Camelo IY; Beachy J; Horton ER
Pediatr Infect Dis J; 2024 Feb; 43(2):145-148. PubMed ID: 37922486
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
Oh DH; Kim JJ; Kim J; Seong H; Lee SJ; Kim YC; Kim EJ; Jung IY; Jeong WY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
BMC Infect Dis; 2018 Jan; 18(1):60. PubMed ID: 29378565
[TBL] [Abstract][Full Text] [Related]
44. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
[TBL] [Abstract][Full Text] [Related]
46. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
[TBL] [Abstract][Full Text] [Related]
47. Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study.
Reynolds G; Crawford S; Cuenca J; Ghosh N; Newton P
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):147-151. PubMed ID: 34432165
[TBL] [Abstract][Full Text] [Related]
48. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
Youngster I; Shenoy ES; Hooper DC; Nelson SB
Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233
[TBL] [Abstract][Full Text] [Related]
49. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
[TBL] [Abstract][Full Text] [Related]
50. Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
Willekens R; Puig-Asensio M; Suanzes P; Fernández-Hidalgo N; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Pigrau C; Almirante B
J Antimicrob Chemother; 2022 Jul; 77(8):2288-2295. PubMed ID: 35552420
[TBL] [Abstract][Full Text] [Related]
51. Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
Sarria JC
Am J Med Sci; 2020 Jul; 360(1):3-4. PubMed ID: 32439151
[No Abstract] [Full Text] [Related]
52. Cefazolin therapy for Staphylococcus aureus bacteremia.
Fernández-Guerrero ML; de Górgolas M
Clin Infect Dis; 2005 Jul; 41(1):127. PubMed ID: 15937778
[No Abstract] [Full Text] [Related]
53. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Stryjewski ME; Szczech LA; Benjamin DK; Inrig JK; Kanafani ZA; Engemann JJ; Chu VH; Joyce MJ; Reller LB; Corey GR; Fowler VG
Clin Infect Dis; 2007 Jan; 44(2):190-6. PubMed ID: 17173215
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
55. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Ulloa ER; Singh KV; Geriak M; Haddad F; Murray BE; Nizet V; Sakoulas G
Clin Infect Dis; 2020 Sep; 71(6):1413-1418. PubMed ID: 31773134
[TBL] [Abstract][Full Text] [Related]
56. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
[TBL] [Abstract][Full Text] [Related]
57. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line.
Cunha BA; Hamid N; Kessler H; Parchuri S
Heart Lung; 2005; 34(6):442-7. PubMed ID: 16324966
[TBL] [Abstract][Full Text] [Related]
58. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
[TBL] [Abstract][Full Text] [Related]
59. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
[TBL] [Abstract][Full Text] [Related]
60. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Shorr AF; Kunkel MJ; Kollef M
J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
